Cargando…

TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells

ATP7B is a hepato-specific Golgi-located ATPase, which plays a key role in the regulation of copper (Cu) homeostasis and signaling. In response to elevated Cu levels, ATP7B traffics from the Golgi to endo-lysosomal structures, where it sequesters excess copper and further promotes its excretion to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petruzzelli, Raffaella, Mariniello, Marta, De Cegli, Rossella, Catalano, Federico, Guida, Floriana, Di Schiavi, Elia, Polishchuk, Roman S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774088/ https://www.ncbi.nlm.nih.gov/pubmed/35053335 http://dx.doi.org/10.3390/cells11020219

Ejemplares similares

Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs
por: Petruzzelli, Raffaella, et al.
Publicado: (2019)

Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin
por: Mariniello, Marta, et al.
Publicado: (2020)

EGR1 drives cell proliferation by directly stimulating TFEB transcription in response to starvation
por: Cesana, Marcella, et al.
Publicado: (2023)

TFEB and TFE3 control glucose homeostasis by regulating insulin gene expression
por: Pasquier, Adrien, et al.
Publicado: (2023)

TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
por: Di Malta, Chiara, et al.
Publicado: (2023)

Infantile ATP7B-Related End-Stage Liver Disease: An Exceptional Wilson Disease Phenotype From Consecutive Generations
por: Nicastro, Emanuele, et al.
Publicado: (2021)

Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice
por: Padula, Agnese, et al.
Publicado: (2022)

Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
por: Spampanato, Carmine, et al.
Publicado: (2013)

Cross-validation of genes potentially associated with neoadjuvant chemotherapy and platinum-based chemoresistance in epithelial ovarian carcinoma
por: Zhang, Kai, et al.
Publicado: (2020)

A splicing variant of TFEB negatively regulates the TFEB-autophagy pathway
por: Park, Jee-Yun, et al.
Publicado: (2021)

TFEB Signalling-Related MicroRNAs and Autophagy
por: Corà, Davide, et al.
Publicado: (2021)

TFE3 regulates whole‐body energy metabolism in cooperation with TFEB
por: Pastore, Nunzia, et al.
Publicado: (2017)

2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion
por: Khamaisi, Hazem, et al.
Publicado: (2022)

Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells
por: Koren Carmi, Yifat, et al.
Publicado: (2023)

AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
por: Gatto, Francesca, et al.
Publicado: (2017)

REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer
por: Lavacchi, Daniele, et al.
Publicado: (2020)

ATP12A Proton Pump as an Emerging Therapeutic Target in Cystic Fibrosis and Other Respiratory Diseases
por: Dębczyński, Michał, et al.
Publicado: (2023)

TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study
por: Bertozzi, Serena, et al.
Publicado: (2021)

Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency
por: Pastore, Nunzia, et al.
Publicado: (2013)

ATP13A2 activates the pentose phosphate pathway to promote colorectal cancer growth though TFEB‐PGD axis
por: Zhang, Fan, et al.
Publicado: (2023)

Surviving starvation simply without TFEB
por: Soukas, Alexander A., et al.
Publicado: (2019)

TFEB Biology and Agonists at a Glance
por: Chen, Mingyue, et al.
Publicado: (2021)

Lysosomal calcium signaling regulates autophagy via calcineurin and TFEB
por: Medina, Diego L., et al.
Publicado: (2015)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study
por: Lou, Emil, et al.
Publicado: (2019)

Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance
por: Giddings, Emily L., et al.
Publicado: (2021)

The TFEB-TGIF1 axis regulates EMT in mouse epicardial cells
por: Astanina, Elena, et al.
Publicado: (2022)

TFEB controls vascular development by regulating the proliferation of endothelial cells
por: Doronzo, Gabriella, et al.
Publicado: (2018)

Downregulated Salt-inducible Kinase 3 Expression Promotes Chemoresistance in Serous Ovarian Cancer via the ATP‐binding Cassette Protein ABCG2
por: Liang, Yu-Ling, et al.
Publicado: (2019)

High Expression Levels of AGGF1 and MFAP4 Predict Primary Platinum-Based Chemoresistance and are Associated with Adverse Prognosis in Patients with Serous Ovarian Cancer
por: Zhao, Haiyue, et al.
Publicado: (2019)

Transition metals activate TFEB in overexpressing cells
por: Peña, Karina A., et al.
Publicado: (2015)

MITF and TFEB cross-regulation in melanoma cells
por: Ballesteros-Álvarez, Josué, et al.
Publicado: (2020)

Role of TFEB in Autophagy and the Pathogenesis of Liver Diseases
por: Yan, Shengmin
Publicado: (2022)

TFEB‐dependent lysosome biogenesis is required for senescence
por: Curnock, Rachel, et al.
Publicado: (2023)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancer
por: Kim, Yi Rang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3h6rd9m7ga876pejfgbhsdh8pu